Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011864) titled 'Utilizing lipid-lowering therapy with moderate-intensity statin plus ezetimibe in chronic kidney disease patients with concomitant atherosclerotic cardiovascular disease: ULTRA-CKD trial' on April 16.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Yonsei University Health System, Severance Hospital
Condition:
Diseases of the genitourinary system
Intervention:
Drug : Two lipid-lowering strategies will be compared. (1) The high-intensity statin monotherapy group will receive atorvastatin 40 mg o...